Skip to main content
Clinical Trials/NCT01793961
NCT01793961
Completed
Not Applicable

Effects of Chronic Intake of Cannabis on Contrast Sensitivity

University Hospital, Strasbourg, France0 sites95 target enrollmentMarch 22, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cannabis Dependence
Sponsor
University Hospital, Strasbourg, France
Enrollment
95
Primary Endpoint
The contrast detection treshold
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Rates of driving under the influence of cannabis have risen in recent years. Cannabis is involved in 1/3 of motor vehicle collisions. The chronic use of cannabis is known to affect dopaminergic regulation and may thus impair contrast sensitivity. In turn, contrast sensitivity disorders could originate difficulties to anticipate and avoid collision with objects, especially when objects are in movement. The investigators goal is to examine the effects of a chronic intake of cannabis on contrast sensitivity. The observed values will be compared to standard references. In addition, since smoking cannabis is always associated with tobacco, the investigators will control the effects of tobacco on contrast sensitivity.

In this study, the investigators will include 36 cannabis addicts, 36 tobacco addicts and 36 no smokers. The investigators will present gratings with different spatial frequencies and the investigators will determine contrast thresholds for static and dynamic (moving) gratings. The investigators predict that cannabis addicts will present abnormal contrast sensitivity especially in case of dynamic presentation of gradings.

Registry
clinicaltrials.gov
Start Date
March 22, 2013
End Date
September 10, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • "Cannabis" Arm
  • patient addicted to cannabis
  • Positive CAST test result
  • Urine tested positive for cannabis metabolites
  • "Tobacco" Arm
  • positive Fagerström test result
  • No cannabis intake in the last year before inclusion
  • No previous history of cannabis use
  • "Healthy Volunteers"
  • No tobacco or cannabis intake in the last year before inclusion

Exclusion Criteria

  • addiction to other substances than cannabis or tobacco
  • benzodiazepine treatment
  • patient with history of benzodiazepine treatment
  • patient with history of general anesthesia in the last 3 months before inclusion
  • patient with history of head trauma
  • Pregnant woman
  • breast feeding woman
  • Adults under supervision or guardianship

Outcomes

Primary Outcomes

The contrast detection treshold

Time Frame: up to 9 days after inclusion

Comparison of the contrast detection threshold of the 3 groups

Similar Trials